Usefulness of 18F-fluorodeoxyglucose positron emission tomography for diagnosing disease activity and monitoring therapeutic response in patients with pulmonary mycobacteriosis
- 18 December 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 36 (4), 632-639
- https://doi.org/10.1007/s00259-008-1009-5
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Evaluation of Therapeutic Response of Tuberculoma Using F-18 FDG Positron Emission TomographyClinical Nuclear Medicine, 2008
- Double-phase 18F-FDG PET-CT for determination of pulmonary tuberculoma activityEuropean Journal of Nuclear Medicine and Molecular Imaging, 2007
- Mycobacterium tuberculosis infection in patients with cancer, the role of 18-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring treatment responseTuberculosis, 2007
- Monitoring Treatment Responses in Patients with Pulmonary TB Using Serial Lung Gallium-67 ScintigraphyAmerican Journal of Roentgenology, 2007
- Uptake Rates of 18F-Fluorodeoxyglucose and 11C-Choline in Lung Cancer and Pulmonary TuberculosisChest, 2003
- Uptake of Fluorine-18-Fluorodeoxyglucose in Pulmonary Mycobacterium avium Complex InfectionInternal Medicine, 2003
- Pulmonary Tuberculoma Evaluated by Means of FDG PET: Findings in 10 CasesRadiology, 2000
- When Tuberculosis Treatment Fails: A Social Behavioral Account of Patient AdherenceAmerican Review of Respiratory Disease, 1993
- An Integrated Approach to Evaluation of the Solitary Pulmonary NoduleMayo Clinic Proceedings, 1990
- Pathology of tuberculosisSeminars in Roentgenology, 1979